Publicaciones (28) Publicaciones en las que ha participado algún/a investigador/a

2024

  1. A Dual-Armed Oncolytic Virus Shows Clinical Efficacy in Advanced Solid Cancers

    Clinical Cancer Research, Vol. 30, Núm. 17, pp. 3649-3651

  2. An artificial intelligence-assisted system versus white light endoscopy alone for adenoma detection in individuals with Lynch syndrome (TIMELY): an international, multicentre, randomised controlled trial

    The Lancet Gastroenterology and Hepatology, Vol. 9, Núm. 9, pp. 802-810

  3. Author Correction: The evolution of lung cancer and impact of subclonal selection in TRACERx (Nature, (2023), 616, 7957, (525-533), 10.1038/s41586-023-05783-5)

    Nature

  4. Characterization of a Trispecific PD-L1 Blocking Antibody That Exhibits EGFR-Conditional 4-1BB Agonist Activity

    ANTIBODIES, Vol. 13, Núm. 2

  5. Chromosomal breaks: another differential gap between early-onset and late-onset colorectal cancers

    British Journal of Surgery, Vol. 111, Núm. 3

  6. Correction to: The role of transanal compared to laparoscopic total mesorectal excision (taTME vs. lapTME) for the treatment of mid‑low rectal cancer in obese patients: outcomes of a multicentre propensity‑matched analysis (Updates in Surgery, (2023), 75, 8, (2191-2200), 10.1007/s13304-023-01676-4)

    Updates in Surgery

  7. Cost-effectiveness of robotic vs laparoscopic distal pancreatectomy. Results from the national prospective trial ROBOCOSTES

    Surgical Endoscopy

  8. DNA electroporation in a vacuum: A “shocking” innovation for vaccines

    Molecular Therapy Nucleic Acids

  9. Decreased expression of the NLRP6 inflammasome is associated with increased intestinal permeability and inflammation in obesity with type 2 diabetes

    Cellular and Molecular Life Sciences, Vol. 81, Núm. 1

  10. Dendritic Cells in Cancer Immunology and Immunotherapy

    Cancers, Vol. 16, Núm. 5

  11. Fcγ receptors and immunomodulatory antibodies in cancer

    Nature Reviews Cancer, Vol. 24, Núm. 1, pp. 51-71

  12. Gut microbiota produces biofilm-associated amyloids with potential for neurodegeneration

    Nature Communications, Vol. 15, Núm. 1

  13. Impact of primary aldosteronism on kidney function: Results from the SPAIN-ALDO registry

    Journal of Hypertension, Vol. 42, Núm. 10, pp. 1805-1812

  14. Increased expression of IL-1β in adipose tissue in obesity influences the development of colon cancer by promoting inflammation

    Journal of Physiology and Biochemistry

  15. MHC Hammer reveals genetic and non-genetic HLA disruption in cancer evolution

    Nature Genetics

  16. Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling

    Nature Communications, Vol. 15, Núm. 1

  17. Neoadjuvant Statistical Algorithm to Predict Individual Risk of Relapse in Patients with Resected Liver Metastases from Colorectal Cancer

    Biomedicines, Vol. 12, Núm. 8

  18. Neoadjuvant therapy versus upfront surgery in resectable pancreatic cancer: reconstructed patient-level meta-analysis of randomized clinical trials

    BJS open, Vol. 8, Núm. 5

  19. Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies

    British Journal of Cancer, Vol. 130, Núm. 5, pp. 869-879

  20. Personalised medicine based on host genetics and microbiota applied to colorectal cancer

    Advances in Genetics (Academic Press Inc.), pp. 411-485